CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,849,905
- in 3 filings, $12.8M under 10b5-1 plans
Net −$12,849,905. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-13 | Garfield Alastair Chief Scientific Officer | Sale 10b5-1 | −2,007 | $116.11 | $233K | 8,051 |
| 2026-08-13 | Garfield Alastair Chief Scientific Officer | Sale 10b5-1 | −1,556 | $117.08 | $182K | 6,495 |
| 2026-08-13 | Garfield Alastair Chief Scientific Officer | Sale 10b5-1 | −3,400 | $118.28 | $402K | 3,095 |
| 2026-08-13 | Garfield Alastair Chief Scientific Officer | Sale 10b5-1 | −800 | $119.17 | $95K | 2,295 |
| 2026-07-01 | Garfield Alastair Chief Scientific Officer | Exercise or conversion | +4,445 | 12,208 | ||
| 2026-07-01 | Garfield Alastair Chief Scientific Officer | Shares withheld for taxes | −2,150 | $110.41 | $237K | 10,058 |
| 2026-07-01 | Garfield Alastair Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −4,445 | 8,888 | ||
| 2026-02-11 | Garfield Alastair Chief Scientific Officer | Grant or award · Restricted Stock Units | +16,650 | 16,650 | ||
| 2026-02-11 | Garfield Alastair Chief Scientific Officer | Grant or award · Stock Options (Right to Buy) | +25,000 | 25,000 | ||
| 2026-02-01 | Garfield Alastair Chief Scientific Officer | Exercise or conversion | +6,663 | 9,789 | ||
| 2026-02-01 | Garfield Alastair Chief Scientific Officer | Shares withheld for taxes | −2,026 | $108.99 | $221K | 7,763 |
| 2026-02-01 | Garfield Alastair Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −6,663 | 19,987 | ||
| 2025-07-02 | Garfield Alastair Chief Scientific Officer | Sale 10b5-1 | −1,313 | $64.81 | $85K | 3,132 |
| 2025-07-02 | Garfield Alastair Chief Scientific Officer | Sale 10b5-1 | −6 | $64.60 | $388 | 3,126 |
| 2025-07-01 | Garfield Alastair Chief Scientific Officer | Exercise or conversion 10b5-1 | +4,445 | 4,445 | ||
| 2025-07-01 | Garfield Alastair Chief Scientific Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −4,445 | 13,333 | ||
| 2025-02-14 | Garfield Alastair Chief Scientific Officer | Grant or award · Restricted Stock Units | +26,650 | 26,650 | ||
| 2025-02-14 | Garfield Alastair Chief Scientific Officer | Grant or award · Stock Options (Right to Buy) | +40,000 | 40,000 | ||
| 2024-07-08 | Garfield Alastair Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +53,333 | 53,333 | ||
| 2024-07-08 | Garfield Alastair Chief Scientific Officer | Grant or award · Restricted Stock Units | +17,778 | 17,778 |
Page 1 of 1 · 20 trades